Pharmacy Pricing Fraud

Brigham reveals the troubling dynamics of pharmacy pricing and the insurance industry's manipulation of costs. He highlights a staggering $230 million in fraud discovered by Ohio's investigation into gap pricing, where insurers profit by misleading states on drug costs. This systemic issue not only affects small pharmacies but also burdens taxpayers, as states could negotiate better prices directly with pharmaceutical companies.